These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9580609)
1. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. Tao Q; Abood ME J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. Showalter VM; Compton DR; Martin BR; Abood ME J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477 [TBL] [Abstract][Full Text] [Related]
3. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. Felder CC; Joyce KE; Briley EM; Glass M; Mackie KP; Fahey KJ; Cullinan GJ; Hunden DC; Johnson DW; Chaney MO; Koppel GA; Brownstein M J Pharmacol Exp Ther; 1998 Jan; 284(1):291-7. PubMed ID: 9435190 [TBL] [Abstract][Full Text] [Related]
4. Characterization of two cloned human CB1 cannabinoid receptor isoforms. Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742 [TBL] [Abstract][Full Text] [Related]
5. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099 [TBL] [Abstract][Full Text] [Related]
6. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Bouaboula M; Desnoyer N; Carayon P; Combes T; Casellas P Mol Pharmacol; 1999 Mar; 55(3):473-80. PubMed ID: 10051530 [TBL] [Abstract][Full Text] [Related]
7. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses. Brodbeck RM; Sachais BS; Krause JE Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation. Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034 [TBL] [Abstract][Full Text] [Related]
9. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Mo FM; Offertáler L; Kunos G Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151 [TBL] [Abstract][Full Text] [Related]
10. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors. Nebane NM; Kellie B; Song ZH FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Wright K; Rooney N; Feeney M; Tate J; Robertson D; Welham M; Ward S Gastroenterology; 2005 Aug; 129(2):437-53. PubMed ID: 16083701 [TBL] [Abstract][Full Text] [Related]
13. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. Sterin-Borda L; Del Zar CF; Borda E Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship. Rao GK; Kaminski NE J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496 [TBL] [Abstract][Full Text] [Related]
15. The neurobiology and evolution of cannabinoid signalling. Elphick MR; Egertová M Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486 [TBL] [Abstract][Full Text] [Related]
16. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling. Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511 [TBL] [Abstract][Full Text] [Related]
17. The CB1 cannabinoid receptor in the brain. Howlett AC Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174 [TBL] [Abstract][Full Text] [Related]
18. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Jagerschmidt A; Guillaume N; Goudreau N; Maigret B; Roques BP Mol Pharmacol; 1995 Nov; 48(5):783-9. PubMed ID: 7476907 [TBL] [Abstract][Full Text] [Related]
19. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells. Monk PN; Pease JE; Marland G; Barker MD Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584 [TBL] [Abstract][Full Text] [Related]
20. Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Tao Q; McAllister SD; Andreassi J; Nowell KW; Cabral GA; Hurst DP; Bachtel K; Ekman MC; Reggio PH; Abood ME Mol Pharmacol; 1999 Mar; 55(3):605-13. PubMed ID: 10051546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]